Hormonal evaluation in relation to phenotype and genotype in 286 patients with a disorder of sex development from Indonesia

Authors:

Abstract
Summary: Objective: The objective of this study was to determine the aetiological spectrum of disorders of sex development (DSD) in a large cohort of underprivileged and undiagnosed patients from Indonesia.Methods: A total of 286 patients with atypical external and/or internal genitalia were evaluated using clinical, hormonal, molecular genetic and histological parameters.Results: The age (years) at presentation was 0–0·5 in 41 (14·3%), >0·5–12 in 181 (63·3%) and >12 in 64 cases (22·4%). 46,XY DSDwas most common (68·2%,n= 195), 46,XX DSDwas found in 23·4% (n= 67) and sex chromosomalDSDin 8·4% (n= 24). In 61·2% of 46,XX DSDpatients, 17·9% of 46,XY DSDpatients and all sex chromosomeDSDpatients (29·4% in total), a final diagnosis was reached based on genetic or histological gonadal tissue evaluation. 17‐hydroxyprogesterone and androstenedione levels were the most distinctive parameters in 46,XX DSDpatients. In 46,XY DSD, diagnostic groups were identified based on the external masculinization score: androgen action disorder (AAD), unknown male undermasculinization (UMU), and gonadal dysgenesis (GD).LH,FSHand testosterone levels were most informative especially in the older age group.HCGtests were of no additional value as no patients with androgen synthesis disorders were found. Hormonal profiles of patients with sex chromosomeDSDand a Y‐chromosome sequence containing karyotype showed high levels ofLHandFSH, and low levels ofAMH, inhibin B and testosterone compared with the normal male range. Gene mutations were found in all patients withCAH, but in only 24·5% and 1·8% of patients withAADandUMU. In 32% of 46,XY GDpatients, copy number variants of different genes were found.Conclusion: A stepwise diagnostic approach led to a molecularly or histologically proven final diagnosis in 29·4% of the patients. The most informative parameters were serum levels of 17‐hydroxyprogesterone and androstenedione in 46,XX DSDpatients, and serumLH,FSHand testosterone levels in 46,XY DSDpatients.

This publication has 39 references indexed in Scilit: